Viewing Study NCT05607004

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:55 PM
Ignite Modification Date: 2026-05-05 @ 4:08 AM
Study NCT ID: NCT05607004
Status: RECRUITING
Last Update Posted: 2025-10-30
First Post: 2022-10-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Sponsor: Atossa Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Neoplasms View
None Invasive Breast Cancer View
None Estrogen-receptor-positive Breast Cancer View
None HER2-negative Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None breast cancer View
None ER+/HER2- View
None endocrine therapy View
None neoadjuvant View
None (Z)-endoxifen View
None exemestane View
None goserelin View
None Ki-67 View
None estrogen receptor negative View
None human epidermal growth factor receptor 2 negative View
None Stage II View
None tamoxifen View
None PKCB1 View